Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

OTULIN Antagonizes LUBAC Signaling by Specifically Hydrolyzing Met1-Linked Polyubiquitin
Kirstin Keusekotten, P.R. Elliott, Laura Glockner, et al.
Cell (2013) Vol. 153, Iss. 6, pp. 1312-1326
Open Access | Times Cited: 437

Showing 1-25 of 437 citing articles:

Ubiquitin modifications
Kirby N. Swatek, David Komander
Cell Research (2016) Vol. 26, Iss. 4, pp. 399-422
Open Access | Times Cited: 1661
30 Years of NF-κB: A Blossoming of Relevance to Human Pathobiology
Qian Zhang, Michael J. Lenardo, David Baltimore
Cell (2017) Vol. 168, Iss. 1-2, pp. 37-57
Open Access | Times Cited: 1647
MEROPS: the database of proteolytic enzymes, their substrates and inhibitors
Neil D. Rawlings, A. John Barrett, Alex Bateman
Nucleic Acids Research (2011) Vol. 40, Iss. D1, pp. D343-D350
Open Access | Times Cited: 1534
TNF biology, pathogenic mechanisms and emerging therapeutic strategies
George D. Kalliolias, Lionel B. Ivashkiv
Nature Reviews Rheumatology (2015) Vol. 12, Iss. 1, pp. 49-62
Open Access | Times Cited: 1158
The increasing complexity of the ubiquitin code
Richard G. Yau, Michael Rapé
Nature Cell Biology (2016) Vol. 18, Iss. 6, pp. 579-586
Closed Access | Times Cited: 923
Mechanisms of Deubiquitinase Specificity and Regulation
Tycho E.T. Mevissen, David Komander
Annual Review of Biochemistry (2017) Vol. 86, Iss. 1, pp. 159-192
Open Access | Times Cited: 854
MEROPS: the database of proteolytic enzymes, their substrates and inhibitors
Neil D. Rawlings, Matthew A. Waller, A. John Barrett, et al.
Nucleic Acids Research (2013) Vol. 42, Iss. D1, pp. D503-D509
Open Access | Times Cited: 796
Deubiquitylating enzymes and drug discovery: emerging opportunities
Jeanine A. Harrigan, Xavier Jacq, Niall M.B. Martin, et al.
Nature Reviews Drug Discovery (2017) Vol. 17, Iss. 1, pp. 57-78
Open Access | Times Cited: 716
Breaking the chains: deubiquitylating enzyme specificity begets function
Michael J. Clague, Sylvie Urbé, David Komander
Nature Reviews Molecular Cell Biology (2019) Vol. 20, Iss. 6, pp. 338-352
Closed Access | Times Cited: 677
Limiting inflammation—the negative regulation of NF-κB and the NLRP3 inflammasome
Inna S. Afonina, Zhenyu Zhong, Michael Karin, et al.
Nature Immunology (2017) Vol. 18, Iss. 8, pp. 861-869
Closed Access | Times Cited: 657
OTU Deubiquitinases Reveal Mechanisms of Linkage Specificity and Enable Ubiquitin Chain Restriction Analysis
Tycho E.T. Mevissen, Manuela K. Hospenthal, Paul P. Geurink, et al.
Cell (2013) Vol. 154, Iss. 1, pp. 169-184
Open Access | Times Cited: 543
Ubiquitin chain diversity at a glance
Masato Akutsu, Ivan Đikić, Anja Bremm
Journal of Cell Science (2016) Vol. 129, Iss. 5, pp. 875-880
Open Access | Times Cited: 494
The IκB kinase complex in NF ‐κB regulation and beyond
M. Hinz, Claus Scheidereit
EMBO Reports (2013) Vol. 15, Iss. 1, pp. 46-61
Open Access | Times Cited: 467
Activation of the canonical IKK complex by K63/M1-linked hybrid ubiquitin chains
Christoph H. Emmerich, Alban Ordureau, Sam Strickson, et al.
Proceedings of the National Academy of Sciences (2013) Vol. 110, Iss. 38, pp. 15247-15252
Open Access | Times Cited: 412
A20 in inflammation and autoimmunity
Leen Catrysse, Lars Vereecke, Rudi Beyaert, et al.
Trends in Immunology (2013) Vol. 35, Iss. 1, pp. 22-31
Closed Access | Times Cited: 409
NF-κB: At the Borders of Autoimmunity and Inflammation
Laura Barnabei, Emmanuel Laplantine, William Mbongo, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 395
The Nuclear Factor Kappa B (NF-kB) signaling in cancer development and immune diseases
Mohammad Reza Zinatizadeh, Bettina Schock, Ghanbar Mahmoodi Chalbatani, et al.
Genes & Diseases (2020) Vol. 8, Iss. 3, pp. 287-297
Open Access | Times Cited: 363
Receptor-interacting protein kinase 1 (RIPK1) as a therapeutic target
Lauren Mifflin, Dimitry Ofengeim, Junying Yuan
Nature Reviews Drug Discovery (2020) Vol. 19, Iss. 8, pp. 553-571
Open Access | Times Cited: 341
The demographics of the ubiquitin system
Michael J. Clague, Claire Heride, Sylvie Urbé
Trends in Cell Biology (2015) Vol. 25, Iss. 7, pp. 417-426
Closed Access | Times Cited: 319
Screening of DUB activity and specificity by MALDI-TOF mass spectrometry
Maria Stella Ritorto, Richard Ewan, Ana B. Pérez‐Oliva, et al.
Nature Communications (2014) Vol. 5, Iss. 1
Open Access | Times Cited: 310
Ubiquitination in the regulation of inflammatory cell death and cancer
Peter E. Cockram, Matthias Kist, Sumit Prakash, et al.
Cell Death and Differentiation (2021) Vol. 28, Iss. 2, pp. 591-605
Open Access | Times Cited: 310
Principles of Ubiquitin-Dependent Signaling
Eugene Oh, David Akopian, Michael Rapé
Annual Review of Cell and Developmental Biology (2018) Vol. 34, Iss. 1, pp. 137-162
Closed Access | Times Cited: 295
USP30 and parkin homeostatically regulate atypical ubiquitin chains on mitochondria
Christian N. Cunningham, Joshua M. Baughman, Lilian Phu, et al.
Nature Cell Biology (2015) Vol. 17, Iss. 2, pp. 160-169
Closed Access | Times Cited: 294
RIPK1 and RIPK3: critical regulators of inflammation and cell death
Kim Newton
Trends in Cell Biology (2015) Vol. 25, Iss. 6, pp. 347-353
Closed Access | Times Cited: 293
The Deubiquitinase OTULIN Is an Essential Negative Regulator of Inflammation and Autoimmunity
Rune Busk Damgaard, Jennifer A. Walker, Paola Marco‐Casanova, et al.
Cell (2016) Vol. 166, Iss. 5, pp. 1215-1230.e20
Open Access | Times Cited: 293
Page 1 - Next Page

Scroll to top